ID   OXSM_HUMAN              Reviewed;         459 AA.
AC   Q9NWU1;
DT   18-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   15-MAR-2017, entry version 134.
DE   RecName: Full=3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial;
DE            EC=2.3.1.41;
DE   AltName: Full=Beta-ketoacyl-ACP synthase;
DE   Flags: Precursor;
GN   Name=OXSM;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Carcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, ENZYME REGULATION,
RP   AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=15668256; DOI=10.1074/jbc.M413686200;
RA   Zhang L., Joshi A.K., Hofmann J., Schweizer E., Smith S.;
RT   "Cloning, expression, and characterization of the human mitochondrial
RT   beta-ketoacyl synthase. Complementation of the yeast CEM1 knock-out
RT   strain.";
RL   J. Biol. Chem. 280:12422-12429(2005).
RN   [5]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-174, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 39-459.
RA   Bunkoczi G., Wu X., Smee C., Gileadi O., Arrowsmith C., Edwards A.,
RA   Sundstrom M., Weigelt J., von Delft F., Oppermann U.;
RT   "Structure of mitochondrial beta-ketoacyl synthase.";
RL   Submitted (DEC-2005) to the PDB data bank.
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 38-459.
RX   PubMed=17242430; DOI=10.1110/ps.062473707;
RA   Christensen C.E., Kragelund B.B., von Wettstein-Knowles P.,
RA   Henriksen A.;
RT   "Structure of the human beta-ketoacyl [ACP] synthase from the
RT   mitochondrial type II fatty acid synthase.";
RL   Protein Sci. 16:261-272(2007).
RN   [9]
RP   VARIANT [LARGE SCALE ANALYSIS] ILE-106.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: May play a role in the biosynthesis of lipoic acid as
CC       well as longer chain fatty acids required for optimal
CC       mitochondrial function. {ECO:0000269|PubMed:15668256}.
CC   -!- CATALYTIC ACTIVITY: Acyl-[acyl-carrier-protein] + malonyl-[acyl-
CC       carrier-protein] = 3-oxoacyl-[acyl-carrier-protein] + CO(2) +
CC       [acyl-carrier-protein].
CC   -!- ENZYME REGULATION: Inhibited by cerulenin.
CC       {ECO:0000269|PubMed:15668256}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3.9 uM for C4-[acyl-carrier-protein]
CC         {ECO:0000269|PubMed:15668256};
CC         KM=1.9 uM for C6-[acyl-carrier-protein]
CC         {ECO:0000269|PubMed:15668256};
CC         KM=10.9 uM for C8-[acyl-carrier-protein]
CC         {ECO:0000269|PubMed:15668256};
CC         KM=1.8 uM for C10-[acyl-carrier-protein]
CC         {ECO:0000269|PubMed:15668256};
CC         KM=9.5 uM for C12-[acyl-carrier-protein]
CC         {ECO:0000269|PubMed:15668256};
CC         KM=50.8 uM for C14-[acyl-carrier-protein]
CC         {ECO:0000269|PubMed:15668256};
CC         Vmax=129 nmol/min/mg enzyme toward C4-[acyl-carrier-protein]
CC         {ECO:0000269|PubMed:15668256};
CC         Vmax=241 nmol/min/mg enzyme toward C6-[acyl-carrier-protein]
CC         {ECO:0000269|PubMed:15668256};
CC         Vmax=271 nmol/min/mg enzyme toward C8-[acyl-carrier-protein]
CC         {ECO:0000269|PubMed:15668256};
CC         Vmax=364 nmol/min/mg enzyme toward C10-[acyl-carrier-protein]
CC         {ECO:0000269|PubMed:15668256};
CC         Vmax=1045 nmol/min/mg enzyme toward C12-[acyl-carrier-protein]
CC         {ECO:0000269|PubMed:15668256};
CC         Vmax=115 nmol/min/mg enzyme toward C14-[acyl-carrier-protein]
CC         {ECO:0000269|PubMed:15668256};
CC         Note=The highest catalytic efficiency is observed for C10-[acyl-
CC         carrier-protein].;
CC   -!- PATHWAY: Lipid metabolism; fatty acid biosynthesis.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:15668256}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NWU1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NWU1-2; Sequence=VSP_041671;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Higher expression in heart,
CC       skeletal muscle, liver and kidney which contain high levels of
CC       active mitochondria. {ECO:0000269|PubMed:15668256}.
CC   -!- SIMILARITY: Belongs to the beta-ketoacyl-ACP synthases family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK000611; BAA91286.1; -; mRNA.
DR   EMBL; AK225260; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC092798; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC008202; AAH08202.1; -; mRNA.
DR   CCDS; CCDS2643.1; -. [Q9NWU1-1]
DR   CCDS; CCDS46780.1; -. [Q9NWU1-2]
DR   RefSeq; NP_001138863.1; NM_001145391.1. [Q9NWU1-2]
DR   RefSeq; NP_060367.1; NM_017897.2. [Q9NWU1-1]
DR   RefSeq; XP_006713279.1; XM_006713216.3. [Q9NWU1-1]
DR   RefSeq; XP_016862202.1; XM_017006713.1. [Q9NWU1-1]
DR   UniGene; Hs.55781; -.
DR   PDB; 2C9H; X-ray; 1.80 A; A=39-459.
DR   PDB; 2IWY; X-ray; 2.06 A; A/B=38-459.
DR   PDB; 2IWZ; X-ray; 1.65 A; A/B=38-459.
DR   PDBsum; 2C9H; -.
DR   PDBsum; 2IWY; -.
DR   PDBsum; 2IWZ; -.
DR   ProteinModelPortal; Q9NWU1; -.
DR   SMR; Q9NWU1; -.
DR   BioGrid; 120328; 9.
DR   IntAct; Q9NWU1; 1.
DR   STRING; 9606.ENSP00000280701; -.
DR   SwissLipids; SLP:000001258; -.
DR   iPTMnet; Q9NWU1; -.
DR   PhosphoSitePlus; Q9NWU1; -.
DR   SwissPalm; Q9NWU1; -.
DR   BioMuta; OXSM; -.
DR   DMDM; 74753030; -.
DR   EPD; Q9NWU1; -.
DR   MaxQB; Q9NWU1; -.
DR   PaxDb; Q9NWU1; -.
DR   PeptideAtlas; Q9NWU1; -.
DR   PRIDE; Q9NWU1; -.
DR   Ensembl; ENST00000280701; ENSP00000280701; ENSG00000151093. [Q9NWU1-1]
DR   Ensembl; ENST00000420173; ENSP00000411303; ENSG00000151093. [Q9NWU1-2]
DR   GeneID; 54995; -.
DR   KEGG; hsa:54995; -.
DR   UCSC; uc003cdn.4; human. [Q9NWU1-1]
DR   CTD; 54995; -.
DR   GeneCards; OXSM; -.
DR   HGNC; HGNC:26063; OXSM.
DR   HPA; HPA021293; -.
DR   HPA; HPA021300; -.
DR   HPA; HPA021337; -.
DR   MIM; 610324; gene.
DR   neXtProt; NX_Q9NWU1; -.
DR   OpenTargets; ENSG00000151093; -.
DR   PharmGKB; PA142671214; -.
DR   eggNOG; KOG1394; Eukaryota.
DR   eggNOG; COG0304; LUCA.
DR   GeneTree; ENSGT00530000063309; -.
DR   HOGENOM; HOG000060166; -.
DR   HOVERGEN; HBG082096; -.
DR   InParanoid; Q9NWU1; -.
DR   KO; K09458; -.
DR   OMA; TALNFQT; -.
DR   OrthoDB; EOG091G071V; -.
DR   PhylomeDB; Q9NWU1; -.
DR   BRENDA; 2.3.1.41; 2681.
DR   SABIO-RK; Q9NWU1; -.
DR   UniPathway; UPA00094; -.
DR   EvolutionaryTrace; Q9NWU1; -.
DR   GenomeRNAi; 54995; -.
DR   PRO; PR:Q9NWU1; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000151093; -.
DR   CleanEx; HS_OXSM; -.
DR   ExpressionAtlas; Q9NWU1; baseline and differential.
DR   Genevisible; Q9NWU1; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005739; C:mitochondrion; IDA:LIFEdb.
DR   GO; GO:0004315; F:3-oxoacyl-[acyl-carrier-protein] synthase activity; IDA:HGNC.
DR   GO; GO:0006637; P:acyl-CoA metabolic process; IDA:HGNC.
DR   GO; GO:0051792; P:medium-chain fatty acid biosynthetic process; IDA:HGNC.
DR   GO; GO:0051790; P:short-chain fatty acid biosynthetic process; IDA:HGNC.
DR   Gene3D; 3.40.47.10; -; 2.
DR   InterPro; IPR017568; 3-oxoacyl-ACP_synth-2.
DR   InterPro; IPR018201; Ketoacyl_synth_AS.
DR   InterPro; IPR014031; Ketoacyl_synth_C.
DR   InterPro; IPR014030; Ketoacyl_synth_N.
DR   InterPro; IPR020841; PKS_Beta-ketoAc_synthase_dom.
DR   InterPro; IPR016039; Thiolase-like.
DR   Pfam; PF00109; ketoacyl-synt; 1.
DR   Pfam; PF02801; Ketoacyl-synt_C; 1.
DR   PIRSF; PIRSF000447; KAS_II; 1.
DR   SMART; SM00825; PKS_KS; 1.
DR   SUPFAM; SSF53901; SSF53901; 2.
DR   TIGRFAMs; TIGR03150; fabF; 1.
DR   PROSITE; PS00606; B_KETOACYL_SYNTHASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Acyltransferase; Alternative splicing;
KW   Complete proteome; Fatty acid biosynthesis; Fatty acid metabolism;
KW   Lipid biosynthesis; Lipid metabolism; Mitochondrion; Polymorphism;
KW   Reference proteome; Transferase; Transit peptide.
FT   TRANSIT       1     27       Mitochondrion. {ECO:0000255}.
FT   CHAIN        28    459       3-oxoacyl-[acyl-carrier-protein]
FT                                synthase, mitochondrial.
FT                                /FTId=PRO_0000232660.
FT   MOD_RES     109    109       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9D404}.
FT   MOD_RES     109    109       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9D404}.
FT   MOD_RES     113    113       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9D404}.
FT   MOD_RES     174    174       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     174    174       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9D404}.
FT   VAR_SEQ     229    311       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041671.
FT   VARIANT     106    106       F -> I (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036064.
FT   STRAND       38     41       {ECO:0000244|PDB:2IWZ}.
FT   STRAND       44     53       {ECO:0000244|PDB:2IWZ}.
FT   STRAND       56     58       {ECO:0000244|PDB:2IWZ}.
FT   HELIX        59     67       {ECO:0000244|PDB:2IWZ}.
FT   STRAND       73     75       {ECO:0000244|PDB:2IWZ}.
FT   HELIX        79     81       {ECO:0000244|PDB:2IWZ}.
FT   STRAND       88     90       {ECO:0000244|PDB:2IWZ}.
FT   STRAND       94     97       {ECO:0000244|PDB:2IWZ}.
FT   HELIX       103    105       {ECO:0000244|PDB:2IWZ}.
FT   HELIX       109    112       {ECO:0000244|PDB:2IWZ}.
FT   HELIX       117    133       {ECO:0000244|PDB:2IWZ}.
FT   HELIX       140    144       {ECO:0000244|PDB:2IWZ}.
FT   STRAND      146    153       {ECO:0000244|PDB:2IWZ}.
FT   HELIX       157    170       {ECO:0000244|PDB:2IWZ}.
FT   HELIX       172    174       {ECO:0000244|PDB:2IWZ}.
FT   HELIX       179    182       {ECO:0000244|PDB:2IWZ}.
FT   HELIX       187    196       {ECO:0000244|PDB:2IWZ}.
FT   HELIX       208    210       {ECO:0000244|PDB:2IWZ}.
FT   HELIX       211    225       {ECO:0000244|PDB:2IWZ}.
FT   STRAND      229    237       {ECO:0000244|PDB:2IWZ}.
FT   HELIX       242    250       {ECO:0000244|PDB:2IWZ}.
FT   TURN        260    262       {ECO:0000244|PDB:2IWZ}.
FT   STRAND      279    287       {ECO:0000244|PDB:2IWZ}.
FT   HELIX       288    293       {ECO:0000244|PDB:2IWZ}.
FT   STRAND      300    309       {ECO:0000244|PDB:2IWZ}.
FT   STRAND      314    316       {ECO:0000244|PDB:2IWZ}.
FT   HELIX       322    335       {ECO:0000244|PDB:2IWZ}.
FT   HELIX       339    341       {ECO:0000244|PDB:2IWZ}.
FT   STRAND      344    346       {ECO:0000244|PDB:2IWZ}.
FT   HELIX       353    367       {ECO:0000244|PDB:2IWZ}.
FT   HELIX       368    372       {ECO:0000244|PDB:2IWZ}.
FT   STRAND      374    377       {ECO:0000244|PDB:2IWZ}.
FT   HELIX       380    383       {ECO:0000244|PDB:2IWZ}.
FT   HELIX       387    389       {ECO:0000244|PDB:2IWZ}.
FT   HELIX       390    404       {ECO:0000244|PDB:2IWZ}.
FT   STRAND      426    428       {ECO:0000244|PDB:2IWZ}.
FT   STRAND      435    437       {ECO:0000244|PDB:2IWZ}.
FT   STRAND      439    446       {ECO:0000244|PDB:2IWZ}.
FT   TURN        447    449       {ECO:0000244|PDB:2IWZ}.
FT   STRAND      450    457       {ECO:0000244|PDB:2IWZ}.
SQ   SEQUENCE   459 AA;  48843 MW;  B2EF550CD354F18C CRC64;
     MSNCLQNFLK ITSTRLLCSR LCQQLRSKRK FFGTVPISRL HRRVVITGIG LVTPLGVGTH
     LVWDRLIGGE SGIVSLVGEE YKSIPCSVAA YVPRGSDEGQ FNEQNFVSKS DIKSMSSPTI
     MAIGAAELAM KDSGWHPQSE ADQVATGVAI GMGMIPLEVV SETALNFQTK GYNKVSPFFV
     PKILVNMAAG QVSIRYKLKG PNHAVSTACT TGAHAVGDSF RFIAHGDADV MVAGGTDSCI
     SPLSLAGFSR ARALSTNSDP KLACRPFHPK RDGFVMGEGA AVLVLEEYEH AVQRRARIYA
     EVLGYGLSGD AGHITAPDPE GEGALRCMAA ALKDAGVQPE EISYINAHAT STPLGDAAEN
     KAIKHLFKDH AYALAVSSTK GATGHLLGAA GAVEAAFTTL ACYYQKLPPT LNLDCSEPEF
     DLNYVPLKAQ EWKTEKRFIG LTNSFGFGGT NATLCIAGL
//
